Cargando…

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2

Yes-associated protein (YAP), the downstream effector of the evolutionarily conserved Hippo pathway, promotes cellular proliferation and coordinates certain regenerative responses in mammals. Small molecule activators of YAP may therefore display therapeutic utility in treating disease states involv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bulos, Maya L., Grzelak, Edyta M., Li-Ma, Chloris, Chen, Emily, Hull, Mitchell, Johnson, Kristen A., Bollong, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153145/ https://www.ncbi.nlm.nih.gov/pubmed/37131806 http://dx.doi.org/10.1101/2023.04.19.537449

Ejemplares similares

AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
por: Zhou, Yuhang, et al.
Publicado: (2020)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
por: Salvador, Fernando, et al.
Publicado: (2018)

CircAMOTL1 RNA and AMOTL1 Protein: Complex Functions of AMOTL1 Gene Products
por: Sadlak, Joanna, et al.
Publicado: (2023)

SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023)

SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1
por: Xu, Xiao-Chen, et al.
Publicado: (2023)

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
por: Fedorov, Oleg, et al.
Publicado: (2011)

circAMOTL1 Motivates AMOTL1 Expression to Facilitate Cervical Cancer Growth
por: Ou, Rongying, et al.
Publicado: (2019)

Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth
por: Ragni, Chiara V., et al.
Publicado: (2017)

A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening
por: Nutsch, Kayla, et al.
Publicado: (2023)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
por: Bowler, Elizabeth, et al.
Publicado: (2018)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022)

Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish
por: Agarwala, Sobhika, et al.
Publicado: (2015)

Clk/STY (cdc2-Like Kinase 1) and Akt Regulate Alternative Splicing and Adipogenesis in 3T3-L1 Pre-Adipocytes
por: Li, Pengfei, et al.
Publicado: (2013)

Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
por: Liu, Yuying, et al.
Publicado: (2013)

AmotL2 integrates polarity and junctional cues to modulate cell shape
por: Hultin, Sara, et al.
Publicado: (2017)

Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006)

Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment
por: Cui, Weiyingqi, et al.
Publicado: (2023)

AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin()
por: Couderc, Christophe, et al.
Publicado: (2016)

AMOTL2 mono-ubiquitination by WWP1 promotes contact inhibition by facilitating LATS activation
por: Hwang, Daehee, et al.
Publicado: (2021)

Pharmacology of Modulators of Alternative Splicing
por: Bates, David O., et al.
Publicado: (2017)

Identification and functional comparison of novel alternatively spliced isoforms of human YAP
por: Liu, Lianlian, et al.
Publicado: (2023)

MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis
por: Kantar, Diala, et al.
Publicado: (2021)

AMOTL2-knockdown promotes the proliferation, migration and invasion of glioma by regulating β-catenin nuclear localization
por: Chen, Xingjie, et al.
Publicado: (2021)

Modulation of E-Cadherin Function through the AmotL2 Isoforms Promotes Ameboid Cell Invasion
por: Subramani, Aravindh, et al.
Publicado: (2023)

Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor
por: Ninomiya, Kensuke, et al.
Publicado: (2011)

Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
por: Araki, Shinsuke, et al.
Publicado: (2015)

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
por: Iwai, Kenichi, et al.
Publicado: (2018)

CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker
por: Lin, Jiarui, et al.
Publicado: (2022)

Succinylation of a KEAP1 sensor lysine promotes NRF2 activation
por: Ibrahim, Lara, et al.
Publicado: (2023)

HGG-21. ABERRANT SPLICING OF CLK1 IN PEDIATRIC HIGH-GRADE GLIOMAS DISRUPTS KEY ONCOGENIC TRANSCRIPTIONAL PROGRAMS
por: Naqvi, Ammar, et al.
Publicado: (2023)

RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022)

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
por: Murai, Aiko, et al.
Publicado: (2020)

The E-cadherin/AmotL2 complex organizes actin filaments required for epithelial hexagonal packing and blastocyst hatching
por: Hildebrand, Sebastian, et al.
Publicado: (2017)

CircAMOTL1 Promotes Tumorigenesis Through miR-526b/SIK2 Axis in Cervical Cancer
por: Sun, Zhengwei, et al.
Publicado: (2020)

FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats
por: González-Fernández, Rebeca, et al.
Publicado: (2022)

PKC Regulates YAP Expression through Alternative Splicing of YAP 3′UTR Pre-mRNA by hnRNP F
por: Chu, Wing-Keung, et al.
Publicado: (2021)

hCLK2 couples FANCD2 to stalled replication forks and functions in the mammalian S-phase checkpoint
por: Collis, SJ, et al.
Publicado: (2006)

CLK-2/TEL2 is a conserved component of the nonsense-mediated mRNA decay pathway
por: Guo, Yanwu, et al.
Publicado: (2021)

Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
por: Zu, Mian, et al.
Publicado: (2015)

Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
por: Saldivia, Manuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_flk6atcuimnp4oeu95n8mv9vo1